Use of the 1.5T Elekta Unity MR-Linac was associated with reduced rates of erectile dysfunction at 6, 12, and 18 months in ...

The FDA has granted accelerated approval to avutometinib (VS-6766) plus defactinib (VS-6063) for the treatment of adult ...

Oncology nurses can enhance endometrial cancer recovery by fostering strong social support networks and improving communication.

Pediatric patients with high-risk neuroblastoma had significantly lower 5-year survival rates in induction and/or ...

The FDA approved the use of daratumumab and hyaluronidase-fihj (Darzalex Faspro) for patients who are newly diagnosed with ...

Identity and Independence: Many AYAs are in a developmental stage where they are gaining autonomy. A cancer diagnosis can ...

New data show strong overall survival rates, building on previously reported outcomes with efti plus pembrolizumab for head ...

The selective CDK2 inhibitor INX-315 has been given FDA fast track designation for use in CCNE1-amplified, platinum-resistant ...

Final data from the phase 3 ALCYONE trial support frontline use of daratumumab-based therapy for patients with ...

Panelists discuss how medication adherence significantly impacts chronic myeloid leukemia (CML) treatment outcomes, with research showing even small differences between 90% and 95% adherence to ...

The subcutaneous formulation of daratumumab makes treatment a faster and more tolerable process for patients with multiple ...

The FDA has approved a ready-to-dilute, multi-dose formulation of thiotepa (Tepylute) for use in breast and ovarian ...